Look for:

Our offer for

UCB S.A.


ISIN:
BE0003739530
WKN:
992418

2024/12/13 08:29:11
Price
180.70 EUR
Difference 0.47% (0.85)

General attributes

ISINBE0003739530
SymbolUCB
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)34,472 EUR
BenchmarkBEL 20 INDEX

Market data

Bid (Bid size)181.15 EUR (100)
Ask (Ask size)181.35 EUR (100)
Open180.70 EUR
High180.70 EUR
Low180.70 EUR
Close (prev. day)179.85 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures23
Related Options-

PDF Downloads

Company report: UCB S.A.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/12/13 08:29:11
Price
180.70 EUR
Difference 0.47% (0.85)

General attributes

ISINBE0003739530
SymbolUCB
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)34,472 EUR
BenchmarkBEL 20 INDEX

Market data

Bid (Bid size)181.15 EUR (100)
Ask (Ask size)181.35 EUR (100)
Open180.70 EUR
High180.70 EUR
Low180.70 EUR
Close (prev. day)179.85 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6m1Y3Y
Perf (%)+36.98%+134.73%+79.85%
Perf (abs.)+48.55+103.23+79.85
Beta0.990.880.69
Volatility26.7528.3328.49
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)182.18 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)180.19 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)168.06 EUR (0)
Ø price 250 days | Ø volume 250 days (pcs.)135.07 EUR (1)
YTD High | date190.20 EUR (2024/12/04)
YTD Low | date78.94 EUR (2024/01/03)
52 Weeks High | date190.20 EUR (2024/12/04)
52 Weeks Low | date72.26 EUR (2023/12/18)

All listings for UCB S.A.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2024/12/1309:05182.25 EUR0.001
Tradegate2024/12/1309:43181.20 EUR0.014
Stuttgart2024/12/1309:31181.05 EUR0.002
Munich2024/12/1308:00180.20 EUR0.001
Frankfurt2024/12/1308:05180.30 EUR0.001
FINRA other OTC Issues2024/11/1818:02174.00 USD0.071
Euronext Milan MTF Trading After Hours---0.00-
Euronext Brussels2024/12/1309:50181.35 EUR0.71202
Duesseldorf2024/12/1308:10179.85 EUR0.001
Berlin2024/12/1308:29180.70 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2611&ID_TYPE_IMAGE_LOGO=2

Contact Details

UCB SA
- -
Allée de la Recherche, 60 - 1070 Brüssel
Telefon: +32-2-559-99-99
Fax: +
E-mail: contactucb@ucb.com

PDF Downloads

Company report: UCB S.A.PDF Download

Company Profile

UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

Members of Management Board

Jean-Christophe TellierChairman of Managing Board
Alistair HenryMember of Executive Committee
Denelle Waynick JohnsonMember of Executive Committee
Emmanuel CaeymaexMember of Executive Committee
Fiona du MonceauMember of Executive Committee
Iris Löw-FriedrichMember of Executive Committee
Jean Luc FleurialMember of Executive Committee
Kirsten Lund-JurgensenMember of Executive Committee
Sandrine DufourMember of Executive Committee

Board of directors

Jonathan PeacockChairman of Supervisory Board
Dame DaviesMember of Supervisory Board
Dolca ThomasMember of Supervisory Board
Jan BergerMember of Supervisory Board
Susan GasserMember of Supervisory Board
Charles-Antoine JanssenMember of Supervisory Board
Cyril JanssenMember of Supervisory Board
Jonkheer Cédric van RijckevorselMember of Supervisory Board
Maëlys CastellaMember of Supervisory Board
Nefertiti GreeneMember of Supervisory Board
Pierre GurdjianMember of Supervisory Board
Rodolfo SavitzkyMember of Supervisory Board
Ulf Arne WiinbergMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer